IS5898A - 5HT1 viðtaka gerandefni og metóklópramíð til meðhöndlunar á mígreni - Google Patents
5HT1 viðtaka gerandefni og metóklópramíð til meðhöndlunar á mígreniInfo
- Publication number
- IS5898A IS5898A IS5898A IS5898A IS5898A IS 5898 A IS5898 A IS 5898A IS 5898 A IS5898 A IS 5898A IS 5898 A IS5898 A IS 5898A IS 5898 A IS5898 A IS 5898A
- Authority
- IS
- Iceland
- Prior art keywords
- metoclopramide
- migraine
- treatment
- receptor agonists
- agonists
- Prior art date
Links
- 102000035038 5-HT1 receptors Human genes 0.000 title 1
- 108091005478 5-HT1 receptors Proteins 0.000 title 1
- 208000019695 Migraine disease Diseases 0.000 title 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 title 1
- 229960004503 metoclopramide Drugs 0.000 title 1
- 206010027599 migraine Diseases 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10632898P | 1998-10-30 | 1998-10-30 | |
| PCT/IB1999/001694 WO2000025778A1 (en) | 1998-10-30 | 1999-10-18 | 5ht1 receptor agonists and metoclopramide for the treatment of migraine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5898A true IS5898A (is) | 2001-03-16 |
Family
ID=22310818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5898A IS5898A (is) | 1998-10-30 | 2001-03-16 | 5HT1 viðtaka gerandefni og metóklópramíð til meðhöndlunar á mígreni |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6255334B1 (is) |
| EP (1) | EP1126840A1 (is) |
| JP (1) | JP2002528497A (is) |
| KR (1) | KR20010089363A (is) |
| CN (1) | CN1325304A (is) |
| AP (1) | AP2001002129A0 (is) |
| AR (1) | AR019246A1 (is) |
| AU (1) | AU5994799A (is) |
| BG (1) | BG105534A (is) |
| BR (1) | BR9914901A (is) |
| CA (1) | CA2348543A1 (is) |
| CO (1) | CO4950530A1 (is) |
| CZ (1) | CZ20011468A3 (is) |
| EA (1) | EA200100284A1 (is) |
| EE (1) | EE200100243A (is) |
| GT (1) | GT199900189A (is) |
| HK (1) | HK1040929A1 (is) |
| HR (1) | HRP20010298A2 (is) |
| HU (1) | HUP0104696A3 (is) |
| ID (1) | ID28291A (is) |
| IL (1) | IL141957A0 (is) |
| IS (1) | IS5898A (is) |
| MA (1) | MA26702A1 (is) |
| NO (1) | NO20012013D0 (is) |
| OA (1) | OA11669A (is) |
| PA (1) | PA8484801A1 (is) |
| PE (1) | PE20001284A1 (is) |
| PL (1) | PL347541A1 (is) |
| SK (1) | SK5522001A3 (is) |
| TN (1) | TNSN99203A1 (is) |
| TR (1) | TR200101174T2 (is) |
| TW (1) | TW524692B (is) |
| WO (1) | WO2000025778A1 (is) |
| ZA (1) | ZA200103322B (is) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6579898B2 (en) * | 2001-03-01 | 2003-06-17 | Pfizer Inc. | Compositions having improved bioavailability |
| GB0105131D0 (en) * | 2001-03-01 | 2001-04-18 | Pfizer Ltd | Compositions having improved bioavailability |
| NZ529417A (en) | 2001-05-24 | 2006-11-30 | Alexza Pharmaceuticals Inc | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| WO2002094242A1 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan or zolmitriptan through an inhalation route |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Pharmaceuticals, Inc. | Delivery of drug esters through an inhalation route |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US7766013B2 (en) * | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
| WO2003041693A1 (en) * | 2001-11-09 | 2003-05-22 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
| EP1446102A1 (en) | 2001-11-21 | 2004-08-18 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
| EP1503744A1 (en) | 2002-05-13 | 2005-02-09 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
| US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| CN101371843B (zh) | 2002-11-26 | 2012-09-26 | 艾利斯达医药品公司 | 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用 |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| ATE510174T1 (de) | 2003-05-21 | 2011-06-15 | Alexza Pharmaceuticals Inc | Schlag gezündete unabhängige heizeinheit |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| EP1765300A2 (en) * | 2004-06-10 | 2007-03-28 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| US20050282879A1 (en) * | 2004-06-17 | 2005-12-22 | Foad Salehani | Methods and composition for treatment of migraine and symptoms thereof |
| AU2004322756B2 (en) | 2004-08-12 | 2011-04-14 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| JP5833804B2 (ja) * | 2005-04-13 | 2015-12-16 | ニューラクソン，インコーポレーテッド | Ｎｏｓ阻害活性を有する置換インドール化合物 |
| TW200808780A (en) * | 2006-04-13 | 2008-02-16 | Neuraxon Inc | 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity |
| US20080139510A1 (en) * | 2006-12-07 | 2008-06-12 | Abe Rose | Treatment of migraine headaches with sublingual amino acids |
| US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| CA2705422A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
| MX2010005343A (es) * | 2007-11-16 | 2010-08-09 | Neuraxon Inc | Compuestos indola 3, 5-sustituidos que tienen actividad inhibidora de la re-absorcion y el reciclo de nos y norepinefrina. |
| MX356032B (es) * | 2007-11-16 | 2018-04-11 | Neuraxon Inc | Compuestos indola y métodos para tratar el dolor visceral. |
| AU2013202680C1 (en) * | 2008-04-28 | 2016-06-23 | Zogenix, Inc. | Novel formulations for treatment of migraine |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698571A (en) * | 1994-10-05 | 1997-12-16 | Eli Lilly And Company | 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| IL127956A0 (en) * | 1996-07-11 | 1999-11-30 | Farmarc Nederland Bv | Inclusion complex containing indole selective serotonin agonist |
| GB9709739D0 (en) | 1997-05-14 | 1997-07-02 | Merck Sharp & Dohme | Pharmaceutical formulation |
-
1999
- 1999-09-01 US US09/387,990 patent/US6255334B1/en not_active Expired - Fee Related
- 1999-10-18 EP EP99971318A patent/EP1126840A1/en not_active Withdrawn
- 1999-10-18 EE EEP200100243A patent/EE200100243A/xx unknown
- 1999-10-18 ID IDW00200100930A patent/ID28291A/id unknown
- 1999-10-18 HU HU0104696A patent/HUP0104696A3/hu unknown
- 1999-10-18 IL IL14195799A patent/IL141957A0/xx unknown
- 1999-10-18 AU AU59947/99A patent/AU5994799A/en not_active Abandoned
- 1999-10-18 BR BR9914901-0A patent/BR9914901A/pt not_active IP Right Cessation
- 1999-10-18 CN CN99812756A patent/CN1325304A/zh active Pending
- 1999-10-18 PL PL99347541A patent/PL347541A1/xx not_active Application Discontinuation
- 1999-10-18 KR KR1020017005271A patent/KR20010089363A/ko not_active Ceased
- 1999-10-18 TR TR2001/01174T patent/TR200101174T2/xx unknown
- 1999-10-18 EA EA200100284A patent/EA200100284A1/ru unknown
- 1999-10-18 JP JP2000579219A patent/JP2002528497A/ja active Pending
- 1999-10-18 SK SK552-2001A patent/SK5522001A3/sk unknown
- 1999-10-18 CA CA002348543A patent/CA2348543A1/en not_active Abandoned
- 1999-10-18 AP APAP/P/2001/002129A patent/AP2001002129A0/en unknown
- 1999-10-18 HR HR20010298A patent/HRP20010298A2/hr not_active Application Discontinuation
- 1999-10-18 HK HK02102736.3A patent/HK1040929A1/zh unknown
- 1999-10-18 CZ CZ20011468A patent/CZ20011468A3/cs unknown
- 1999-10-18 WO PCT/IB1999/001694 patent/WO2000025778A1/en not_active Ceased
- 1999-10-18 OA OA1200100100A patent/OA11669A/en unknown
- 1999-10-27 TW TW088118594A patent/TW524692B/zh active
- 1999-10-27 MA MA25827A patent/MA26702A1/fr unknown
- 1999-10-27 PA PA19998484801A patent/PA8484801A1/es unknown
- 1999-10-27 TN TNTNSN99203A patent/TNSN99203A1/fr unknown
- 1999-10-28 AR ARP990105447A patent/AR019246A1/es not_active Application Discontinuation
- 1999-10-29 CO CO99068659A patent/CO4950530A1/es unknown
- 1999-10-29 GT GT199900189A patent/GT199900189A/es unknown
- 1999-10-29 PE PE1999001083A patent/PE20001284A1/es not_active Application Discontinuation
-
2001
- 2001-03-16 IS IS5898A patent/IS5898A/is unknown
- 2001-04-19 US US09/838,440 patent/US20010020036A1/en not_active Abandoned
- 2001-04-24 ZA ZA200103322A patent/ZA200103322B/en unknown
- 2001-04-24 NO NO20012013A patent/NO20012013D0/no not_active Application Discontinuation
- 2001-05-22 BG BG105534A patent/BG105534A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5898A (is) | 5HT1 viðtaka gerandefni og metóklópramíð til meðhöndlunar á mígreni | |
| IS5405A (is) | Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir | |
| NO20006062D0 (no) | Innkapslede spaltningsstoffer, blandinger og fremgangsmåte for anvendelse derav | |
| NO964548D0 (no) | Substituerte sulfonamider som selektive 3 agonister for behandling av diabetes og fedme | |
| NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
| DK1379224T3 (da) | Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese | |
| DE69939929D1 (de) | Osteosynthetische verbindungsvorrichtung | |
| IS6560A (is) | Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni | |
| NO20023216D0 (no) | Instrumentert sementeringsplugg og system for samme | |
| IS5696A (is) | Mótefni gegn CD23, afleiður þeirra og meðferðarnotkun þeirra | |
| IS2494B (is) | Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni | |
| DK1076704T3 (da) | IL-2-selektive agonister og antagonister | |
| NO20004095L (no) | Blandinger og fremgangsmÕter for regulering av lymfocyttaktivering | |
| IS2468B (is) | Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini | |
| IS6303A (is) | Notkun retígabíns til meðhöndlunar á taugasjúkdómatengdum sársauka | |
| IS5131A (is) | Þíazól bensensúlfonamíð sem ß3 gerandefni fyrir meðhöndlun á sykursýki og offitu | |
| PT1212317E (pt) | Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes | |
| NO20010487D0 (no) | Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav | |
| NO20012963L (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| ITMI20001380A0 (it) | Procedimento e dispositivo per variare il contenuto di memoria di apparecchi di comando. | |
| IS2253B (is) | Notkun á eletriptani til fyrirbyggingar á endurteknu mígreni | |
| IT1303677B1 (it) | Dispositivo per il trattamento termico di pezzi. | |
| IS5809A (is) | Samtíma inngjöf ACAT og MMP tálma til meðhöndlunar á skemmdum vegna fituhrörnunar | |
| NO993784D0 (no) | Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene | |
| NO984829L (no) | Operasjonsutstyr og bruks-fremgangsmÕte |